ARE (Alexandria) שווי פירמה כולל

Alexandria (ARE) owns unique biotech campuses, creating a powerful defensive barrier through complex building engineering systems. High business resilience is ensured by long-term leases with major tenants, while the Enterprise Value, according to the quotes provided below, stands at 23994.37. The fund's prospects rely on expanding demand for specialized laboratories and a revival of investment in medicine and biological research.

For Alexandria (ARE), which owns capital-intensive laboratory complexes in US tech hubs, this metric reflects the actual cost of transferring ownership rights to these physical assets. By analyzing the enterprise value, an investor sees the sum of capitalization and debt minus liquidity, which allows for an assessment of borrowing efficiency in managing hyper-local real estate and the determination of a fair buyout price for the business.